Medical General

VGI Announces the Launch of DISMISS� Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System

2009-03-03T17:46:00.000+02:00

VGI Announces the Launch of DISMISS® Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System

VGI introduces a revolutionary surgical instrument system that is smaller in diameter than a pencil. The DISMISS® instrument system is designed specifically for the implantation of the VerteLoc™ Minimally Invasive Spine Stabilization System and will be unveiled at the Congress of Neurological Surgeons meeting in Phoenix, Arizona starting on March 12, 2009.

Winston-Salem, NC (PRWEB) March 3, 2009 -- VG Innovations, Inc. (www.vginnovations.com) (VGI), announces the launch of a new surgical instrumentation system, named DISMISS®.

"DISMISS® stands for Directional Instrument System for Minimally Invasive Spine Surgery," stated VGI's President and CEO, Dan Grayson. "We have received very positive feedback from our surgeon users, regarding the biomechanical advantages of the VerteLoc™ Minimally Invasive Spine Stabilization system, so the next logical step was to further refine the system's current instrumentation. We have now taken minimally invasive spinal facet fusion to a whole new level with the DISMISS® instruments."

"The DISMISS® instruments, used specifically for the implantation of the VerteLoc™ implants, are smaller in diameter than a pencil," noted Executive Vice President and Chief Technical Officer Dr. Tov Vestgaarden. "In addition, we have not only reduced the size, but also the number of instruments required for surgical implantation. This is just the beginning of a whole new era in surgical instrumentation from VGI."

"New sets of the DISMISS® instruments will be distributed during the second and third quarters of 2009 to select VGI distributors throughout the United States," Grayson added. "These new instruments will allow our distributors to introduce the VerteLoc™ system to a more diverse surgeon base."

The VerteLoc™ Minimally Invasive Spine Stabilization System (www.verteloc.com) is designed to allow earlier intervention in the continuum of spinal care. The procedure should prolong or prevent more invasive spine procedures in indicated patients, which would provide significant benefits to the quality of life versus traditional methods of spinal fusion.

Company Profile

VG Innovations, Inc, is a privately held company and was formed in late 2007. The company is in the business of developing and commercializing proprietary, implantable devices with a specific focus on minimally invasive surgical products that could provide better surgical solutions over present technology. The products are designed to treat specific spinal disease indications that affect millions of people. More information on the company and its products can be found at: www.verteloc.com.

###

Contact Information Dan Grayson

VG Innovations, Inc

http://www.verteloc.com

336-760-2012

The Health Alliance's Dennis Robb Announced Contracting Professional of the Year by The Journal of Healthcare Contracting

2009-03-03T13:45:00.000+02:00

The Health Alliance's Dennis Robb Announced Contracting Professional of the Year by The Journal of Healthcare Contracting

Pioneer in healthcare supply chain honored for accomplishments

Dallas (Vocus) March 3, 2009 -- Dennis Robb, senior vice president, supply chain management (www.broadlane.com), The Health Alliance of Greater Cincinnati, was recently announced 2008 Contracting Professional of the Year by The Journal of Healthcare Contracting.

Described as a pioneer in healthcare for more than three decades, Robb was selected to receive this honor based on his accomplishments in supply chain management and history of clinical and executive leadership.

As the senior vice president of supply chain management (www.broadlane.com) for The Health Alliance of Greater Cincinnati, Robb is continually seeking avenues for improvement for the 929-bed health system and manages its $369 million supply and capital spend. Robb is also responsible for initiation of value analysis committees and leadership of multidisciplinary teams of doctors, nurses, pharmacy, information technology and bioengineering professional for the management of capital procedures, contracting and contract compliance, system-wide standardization, price verification documentation of audited savings, vendor negotiations, environmental responsibility and economic inclusion.

"We congratulate Dennis on his latest achievement," said David Ricker, president and chief executive officer, Broadlane. "He is a valuable member on our Executive Steering Committee, helping drive all contracting decisions and awards. Dennis has also emerged as a leader in Supplier Diversity, working with the Broadlane Supplier Diversity Contracting team to implement the methods by which to execute and track results of The Health Alliance's supplier diversity initiative."

One of Robb's most notable achievements is the 2008 Corris Boyd Leadership and Diversity Award from the Federation of American Hospitals. This award was presented for Robb's efforts to create an environment of cooperation and commitment within The Health Alliance, which helped the health system reach a $23 million diverse supplier spending goal in its first year.

"I work daily with Dennis on supply chain initiatives," said Ruby Kern, vice president, enterprise accounts, Broadlane. "In my 35 years of supply chain experience, I've never come across anyone as passionate as Dennis is about meeting supply chain, environmental and supplier diversity goals."

In 10 months, The Health Alliance reached and exceeded the $23 million target with certified diverse suppliers and was recognized with awards from the Greater Cincinnati and Northern Kentucky African American Chamber of Commerce and the Cincinnati USA Regional Chamber. The number of diverse suppliers grew 360 percent over a year. Over the past three years, the organization has maintained its commitment, spending a total of $90 million with diverse suppliers.

"We are very proud of Dennis' newest honor as Contracting Professional of the Year," said Ken Hanover, chief executive officer, the Health Alliance. "He has done an extraordinary job managing our supply chain. Dennis' optimism, professionalism and commitment to excellence are outstanding attributes, and this recognition is something in which we can all take pride."

About The Journal of Healthcare Contracting

The Journal of Healthcare Contracting is the only publication that is solely devoted to the contracting arena of healthcare. It focuses on the interactions of the four primary stakeholders in healthcare contracting: health systems and their facilities, manufacturers and suppliers, distributors and group purchasing organizations. The participants in the contracting arena will grow to rely on The Journal of Healthcare Contracting for industry understanding, insight into the minds of thought leaders and collaboration opportunities amongst contracting constituents.

About The Health Alliance

The Health Alliance of Greater Cincinnati, which includes the University, Jewish and Fort Hamilton hospitals, Drake Center, West Chester Medical Center and the physicians of Alliance Primary Care, continues to be Cincinnati's largest healthcare provider and recently expanded its physician practice by acquiring Greater Cincinnati Associated Physicians. The Health Alliance, which employs 7,800 people, has been recognized for its progressive supplier diversity and disability services programs. For more information on the Health Alliance, visit

www.health-alliance.com.

About Broadlane

Broadlane is the leading cost management company for healthcare providers. Broadlane's scalable business solutions optimize operational performance and achieve significant cost savings, thereby improving the overall financial performance of its clients. Its core services include supply chain management and clinical workforce management services.

Broadlane's comprehensive supply chain services include:

• Unparalleled national and custom contracting for supplies, pharmaceuticals, equipment and purchased services

• Innovative Procurement Services and purchase transaction management

• Clinical Services for managing clinical preference items and operating room and cath lab spending

• Comprehensive Materials Management Services - including outsourcing

• Informatics - benchmarking, advanced analytics and reporting

• Supply chain technology and e-commerce

Broadlane Workforce Management™ addresses nurses and allied healthcare practitioners and includes:

• External shift and agency management services

• Internal shift management, including electronic shift auctions

• Regional nurse float pool management and internal agency management

• E-commerce workforce exchange linking healthcare providers, clinical staff and agencies, enabling efficient shift management and fulfillment and reconciliation

Broadlane's clients include leading providers such as Advocate Health Care, Ascension Health, Beaumont Hospitals, CHRISTUS Health, Continuum Health Partners, Kaiser Permanente, Kindred Healthcare, MedCath Corporation, New Hanover Regional Medical Center, Sisters of Charity of Leavenworth Health System, Tenet Healthcare, The Health Alliance of Greater Cincinnati, US Oncology and UMass Memorial Health Care.

The company is headquartered in Dallas with offices in Cincinnati, Detroit, Houston, New York City and Oakland. For more information, visit www.broadlane.com.

###

Contact Information Jim Webb

http://www.broadlane.com

972-813-7782

Sunetics' New Laser Paddle Brush for Hair Enhancement Provides Largest Coverage Area of All Hand-Held Devices

2009-03-03T12:46:00.000+02:00

Sunetics' New Laser Paddle Brush for Hair Enhancement Provides Largest Coverage Area of All Hand-Held Devices

New hair enhancement laser device offers best coverage available.

Las Vegas, NV (PRWEB) March 3, 2009 -- Sunetics International announces the official launch of the new Laser Paddle Brush, an advanced at-home hair care device for men and women with weak or thinning hair that delivers a greater degree of low level laser energy to the scalp than any other hand-held unit on the market.

"Sunetics' Laser Paddle Brush is an important advancement for consumers as it provides the maximum level of scalp coverage at a more optimal low level laser energy wavelength than any other 'brush' or 'comb' currently available," said Dr. Charles Maricle, Chief Technological Officer of Sunetics International. "Low level laser therapy has been demonstrated to effectively improve the appearance of hair, making it look fuller, thicker, shinier and healthier."

With the new Laser Paddle Brush, Sunetics has enhanced the size of the laser area by creating three rows of laser diodes utilizing 12 true laser diodes. Sunetics also uses its patented technology to expand the laser beam pattern, thus creating a superior coverage area of laser energy. The Laser Paddle Brush was developed to deliver the largest coverage area of all hand-held devices so that consumers can experience in the privacy of their own homes the maximum amount of laser energy at the optimal wavelength level. The average usage time is just 10 minutes per day, three times per week.

"Customers who use the Sunetics' Laser Paddle Brush for at-home laser hair therapy care will also be able to use it on the road when they travel since it is so portable as well as rechargeable," says John Carullo, Director of Marketing for Sunetics.

Key Facts for Consumers About the Sunetics' Laser Paddle Brush:

• Maximum Laser Energy - Designed with 12 true laser diodes, the most of any other hand-held unit on the market. Each laser diode used for hair rejuvenation has a wavelength of 650 nm.

• Superior Scalp Coverage - Uses multiple, wide-pattern, true laser diodes to provide maximum coverage of the scalp for men and women. The laser diodes are positioned on the brush to produce an expanded elliptical laser light pattern that provides maximum coverage of the scalp.

• Portable - Unlike other hand-held laser devices that are plugged in, the Laser Paddle Brush is cordless and uses a rechargeable battery to make it portable and easier to use with maximum energy.

• Unique Bristle Design - A true laser "brush," the device has over 75 soft, gentle scalp-massaging bristles. The unique soft bristles are designed to not break or damage fine or weakened hair.

• Certified, Patented and Approved - The Laser Paddle Brush is a U.S. patented device (#7,258,695) that is CE-certified and complies with all FDA manufacturing standards and safety regulations for personal use as well as 11 FDA performance standards for laser products.

Evidence for Low Level Laser Hair Therapy:

In January of 2007, the U.S. Food and Drug Administration (FDA) officially cleared the first hand-held laser device (www.fda.gov/cdrh/pdf6/K060305.pdf) to treat hair loss and to re-grow hair.

Previous cosmetic clinical studies performed by Sunetics have shown that, as a result of its laser hair therapy program, 86-percent of participants reported the appearance of healthier hair, 78-percent reported the appearance of thicker hair, 76-percent reported the appearance of fuller hair and 85-percent of the participants reported overall satisfaction with the Sunetics Laser Hair Therapy program.

About Sunetics International

Sunetics International is a leading U.S. manufacturer of low level laser devices that are regularly used by doctors for the care of weak or thinning hair. Sunetics also offers devices for acne, wrinkles and skin rejuvenation. Established in 2003, Sunetics is a registered cosmetic manufacturer with the FDA and provides both hand-held laser devices and in-office clinical laser units. For more information about low level laser devices or products from Sunetics, visit www.sunetics.com or call 1-888-266-2232.

###

Contact Information John Carullo

Sunetics International

http://www.sunetics.com

888-266-2232

LifeMasters Introduces Health Activation Tool to Disease Management Participants

2009-03-02T20:46:00.000+02:00

LifeMasters Introduces Health Activation Tool to Disease Management Participants

Innovator of the PAM™ Assessment in Chronic Disease Coaching

Irvine, Calif. (Vocus) March 2, 2009 -- In keeping with its commitment to implement the latest advances in behavior change, LifeMasters (https://www.lifemasters.com/innovation/) Supported SelfCare, Inc. is the first disease management company in the country to introduce a powerful health activation tool for use with its chronically ill participants.

The Patient Activation Measure™ (PAM™) was developed by Judith Hibbard, Ph.D., and colleagues at the University of Oregon to assess an individual's knowledge, skills and confidence in playing a role in one's own health and healthcare. By understanding participants' "activation levels," LifeMasters health professionals can better tailor participant coaching to an individual's level of activation, helping him or her identify and overcome barriers to behavior change.

"We know that higher levels of activation are correlated with improved self-care behaviors," said LifeMasters CEO Christobel Selecky. "By focusing on increasing a participant's activation level, our health coaches can help LifeMasters participants to develop self-efficacy and greater levels of motivation, which ultimately lead to greater confidence in managing their health. We are very excited about the potential that this tool provides us to improve outcomes and enhance sustained engagement."

LifeMasters is a health improvement company with more than 15 years experience in developing scientifically based interventions that target key cost drivers such as diabetes, congestive heart failure, asthma, coronary artery disease, chronic obstructive pulmonary disease, hypertension, cancer and musculo-skeletal pain. The company began piloting the PAM in 2005. In 2007, it completed a 2-call-center comparison study based on the PAM with Dr. Hibbard and her team and is now widely implementing the use of PAM across all LifeMasters sites and additional research is being considered.

LifeMasters coaches are trained in the use of motivational interviewing techniques - informed by the insight gained from the PAM tool - which allows them to focus on helping participants develop confidence in managing their health (depending on their activation level) rather than on encouraging behaviors they may not be ready to achieve.

The Patient Activation Measure, which is licensed and marketed by Insignia Health, consists of a 10 or 13-question survey that asks people about their beliefs, knowledge and confidence for engaging in a wide range of health behaviors. Based on responses to the survey, each person is assigned an activation score and level. The PAM segments participants into one of four progressively higher activation levels.

At the low end of the spectrum, individuals tend to be passive with regard to managing their health, and may fail to see the connection between their own behaviors and health outcomes. At the high end, individuals understand that relationship and have become good self-managers across a constellation of behaviors. However, even high activation level individuals may benefit from coaching to stay on course when stress occurs.

Answers to the PAM survey give the health professional insight into a participant's frame of reference and help facilitate tailored discussion about what a participant wants to work on. By periodically re-administering the survey and reviewing responses to individual items over time, changes in a participant's activation level can be reassessed and used as a guide for ongoing coaching.

"In using the PAM, LifeMasters is supporting consumers on a journey to improve the self-management competencies that drive health status, and in so doing, helping consumers unlock their potential to flourish," said Chris Delaney, Insignia's Chief Executive Officer.

The level of patient activation varies considerably in the U.S. population, with less than half of the adult population at the highest level of activation, according to a recent study by the Center for Studying Health System Change. More than 85 studies have documented the PAM's ability to effectively measure patient activation and to predict a range of behaviors in wide demographic variability. These include preventive behaviors such as exercise, diet, and smoking cessation, disease-specific self-management behaviors such as medication compliance and health monitoring, and consumer behaviors such as successful interaction with a healthcare provider.

Because of the strong correlation between activation and self-care behaviors, the PAM scores can also greatly enhance the credibility of reported outcomes. While return on investment and closing clinical gaps in care will always be important outcomes measures, the ability to demonstrate a concurrent improvement in activation increases the likelihood that those positive outcomes can be attributed to the health improvement program.

A research project between LifeMasters and Dr. Hibbard's team demonstrated that activation levels and health outcomes can be improved by tailoring participant care plans to the individual's activation level. The full results of this study are expected to be published in June of 2009.

About LifeMasters Supported SelfCare, Inc.

LifeMasters Supported SelfCare, Inc. is a leading provider of health improvement and condition management programs and services that create health partnerships among individuals and their physicians. The programs improve the quality of care for populations with risk factors and

chronic conditions and reduce healthcare cost trends for the nation's leading health plans, employers, retirement systems, labor unions/trusts and governmental organizations. LifeMasters offers programs for individuals with diabetes, congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, hypertension, asthma, cancer, depression and musculo-skeletal pain. LifeMasters' programs are holistically focused, support co-morbidities like depression, and facilitate lifestyle changes such as smoking cessation and weight loss. LifeMasters is accredited by the National Committee for Quality Assurance (NCQA) and URAC. More information can be found at innovation.lifemasters.com (https://www.lifemasters.com/innovation/).

About Insignia Health

Insigna Health is committed to helping consumers develop the behaviors that are crucial to becoming more active and effective members of their own healthcare team. These efforts are anchored by the Patient Activation Measure and the self-management competencies revealed by this assessment tool. With this knowledge, Insignia's tailored coaching resources and self-care products can be leveraged to help individuals begin to master new positive behaviors that are realistic given one's current level of activation. Research has shown consistently that with increased activation comes better health and the more effective and efficient use of healthcare resources. More information can be found at www.insigniahealth.com.

###

Contact Information Abbie Pauley

http://innovation.lifemasters.com

412-926-7093

German Medical Advancement Reflects Major Improvement in Individuals with Common and Chronic Illnesses Related to Immune System Dysfunction

2009-03-02T10:45:00.000+02:00

German Medical Advancement Reflects Major Improvement in Individuals with Common and Chronic Illnesses Related to Immune System Dysfunction

A new preparation highly beneficial in patients with ailments from common skin disorders to hepatitis or HIV, is now available in the US without a prescription. Oral intake of the GKL03 synthetic peptides induces modulation and regulation of the immune system. GKL03 (Thymrevit) is a demonstrably potent immmunomodulator effective in the short term.

Mannheim, Germany -- A new preparation highly beneficial in patients with ailments from common skin disorders to hepatitis or HIV, is now available in the US without a prescription. Oral intake of the GKL03 synthetic peptides induces modulation and regulation of the immune system. GKL03 (Thymrevit) is a demonstrably potent immmunomodulator effective in the short term.

This preparation was first used in 2004 on tumor patients whose immune system was significantly weakened by chemotherapy or radiotherapy which had been carried out or recently administered. All subjects felt significantly better in several chemotherapy phases each time GKL-03 was taken, and also had better excersise tolerance in endurance test. Since 2004, ongoing clinical trials conducted in Germany, has shown GKL-03 to be adventageous in those with tumourigenic disease, cancer or immuno deficiencies. There are unambiguous findings indicating GKL-03 can protect the body from opportunistic infections where the body has been damaged from pre-existing conditions such as chemotherapy, x-rays, or bacterial, fungal or latent viral infections. "Since such a short term improvement of immune disorders is extremely difficult to achieve, I venture to assume with all reserve a positive effect of the GKL-03" --- Dr. Med Knut Briken, Oncology/Immunobiological Cancer Aftercare, Berlin Germany.

Klett-Loch GmbH, a medium size company, located in Mannheim Germany is a top leader in research and development against immune system disorders for over 25 years. Biotechne Complex, Inc. (www.biotechne.com) located in Georgia is designated the North American representative since 1995 assisting in continued support and informational programs.

###

Contact Information Martin Wainright

Biotechne Complex, Inc.

http://www.biotechne.com

800-214-8631

Menersa Demand Spikes on the Heels of Health Report

2009-03-01T10:47:00.000+02:00

Menersa Demand Spikes on the Heels of Health Report

A recent study that was conducted by the National Sleep Foundation (NSF) in the US, involving more than six hundred women between the ages of 43 and 53, has concluded that women who are in the menopausal phase, or who were premenopausal, got less sleep at night due to frequent disturbances that were greatly attributed to the symptoms of menopause; namely hot flashes, and or, night sweats. Many menopausal women, who previously have relied upon popular prescription drugs for treating hormonal pathway imbalances, are now turning to natural cures for menopause, like Menersa, because they utilize proprietary blends of clinically proven botanical alternatives that not only correct hormonal pathway imbalances, but also relieve the symptoms of menopause that can contribute to sleep deprivation.

Manalapan, NJ (PRWEB) March 1, 2009 -- Many of the most important functions of our bodies are controlled by hormonal releases. Some hormones help our body to distribute and process fats. Others control the rates at which we grow hair and skin. And yet others can determine how well we will sleep at night. For the millions of women are entering premenopausal stages, or who are already experiencing menopause, their hormones can be bouncing out of control. So much so that it can greatly affect the amounts of sleep that they receive each night and in turn can be detrimental to their overall wellbeing, quality of life and happiness.

In fact, shifting hormones during the menopausal period can greatly contribute to the lack of sleep or disturbed sleeping patterns, generally related to hot flashes, night sweats and other side effects of hormonal pathway imbalances. During a recent study--which was conducted by the National Sleep Foundation (NSF) in the US--more than six hundred women between the ages of 43 and 53 were asked to make frequent journal entries during their menstrual periods. The studies concluded that women who were showing the earlier signs of menopause got far less sleep at night when compared to those who were still premenopausal. In short: even the earliest symptoms of menopause caused for a greater disturbance of nightly sleep cycles. A trend which increases as the natural phase of menopause sets in.

Yet the most popular prescribed menopause drugs only work to correct hormonal pathway imbalances. Many offer no cure for sleep deprivation or night flashes, which commonly contribute to sleep disturbances during menopause. This is why more women are turning to clinically proven, all-natural menopausal remedies like Menersa--which utilizes the power of a variety of unique botanicals that treat all symptoms of menopause. Menersa is able to also relieve symptoms associated with sleep deprivation by incorporating calming herbs that work to naturally relieve discomforts associated with the symptoms of menopause, and that help to replenish essential and vital bodily nutrients.

"The recent reports of interrupted sleep patterns (as they relate to the symptoms of menopause) has caused a big spike in the online sales of our popular and clinically proven botanical alternative, Menersa," states Constantine Lopez, spokesperson for Vitaloix Labs. "More women are turning to natural cures for menopause that not only work to safely correct hormonal imbalances, but that also offer a cure for common associated symptoms (of menopause) that can really take their toll on the quality of life of the sufferer."

Menersa is an all-natural menopause supplement that is taken daily. It has been clinically proven to be comparable to low-dose transdermal estradiol (Estraderm 25 mcg every 7 days) for relieving hot flashes and the other 34 symptoms of menopause.

For more information on how the all-natural and clinically proven menopause remedy Menersa can relieve the symptoms of menopause safely and efficiently, please visit their website online at: http://www.menersa.com

About Menersa:

• Created by Vitaloix Labs--a leading nutraceutical company

• Relieves the common symptoms associated with menopause naturally, including, but not limited to: hot flashes, mood swings, decreased energy, nervousness, irritability, vaginal irritation, poor sex drive, abnormal weight gain, chronic headaches, fatigue, anxiety, tension and others

• Works to promote healthy weight maintenance and an increased sexual drive

• Specifically targets the support of hormonal pathway imbalances, greatly reducing menopausal symptoms

• Provides the body with a source of naturally-occurring phytoestrogen complexes

• Incorporates calming herbs that work to naturally relieve discomforts associated with the symptoms of menopause, and that helps to replenish essential and vital bodily nutrients

• Uses powerful and clinically proven botanicals to help women enjoy a more natural and healthier sleep cycle during the menopausal phase

• Clinically proven to be a safer alternative to hormone therapy and hormone replacement therapy, and has also been proven to be as equally or more effective than using menopausal products containing soy

• Tedious and lengthy clinical studies provided clear cut evidence that Menersa is comparable to low-dose transdermal estradiol (Estraderm 25 mcg every 7 days) for relieving hot flashes

• No known adverse side effects

• 100% all-natural, safe & effective

• Available online at their website for a generous discount at: http://www.menersa.com

# # #

Contact Information Liz Gilman

Health Web Shopping

http://www.menersa.com

(800) 344-0478

Align International Recruitment - Thinking of Working in New Zealand? A Positive Move in Troubled Times

2009-02-27T09:46:00.000+02:00

Align International Recruitment - Thinking of Working in New Zealand? A Positive Move in Troubled Times

Christchurch, New Zealand (PRWEB) February 27, 2009 -- So, the global economy has tightened up - jobs are becoming harder to find, competition for available job openings is becoming more intense.

You may be considering a move offshore? Align International Recruitment Ltd (http://www.alignrecruitment.com/) is a boutique recruitment company that helps highly skilled people find work in New Zealand. In early 2009 Align Recruitment launched a new website to assist international job seekers find that 'dream job' and 'dream lifestyle'. in New Zealand.

What are the advantages of moving to New Zealand in the current climate?

Right now, off the back of a dip in New Zealand exports, the New Zealand dollar (NZD) is at a low against most major trading partners. In effect, this means that migrants arriving from (for example) the USA are buying homes at half the price over the same period three or four years ago when the dollar was much stronger. New Zealand has also weathered the start of the global downturn with remarkable resilience - thanks largely to a strong agricultural market and limited exposure to the events happening within the securities market. The recent New Zealand elections saw a right wing 'National' led government assume the reins placing particular emphasis on public spending and tax cuts to continue to stimulate the New Zealand economy.

Another major attraction to New Zealand is opportunity. New Zealand has a number of skill shortage areas as defined by the Department of Labour, in particular in Healthcare. You can visit the Align Recruitment website to browse Clinical Psychologist jobs (http://www.alignrecruitment.com/jobs/-/Clinical-Psychology.php), Physician jobs (http://www.alignrecruitment.com/jobs/-/Medical-Officer-Doctor-Physician.php), jobs for Nurses (http://www.alignrecruitment.com/jobs/-/Nursing.php), Physiotherapist vacancies and Occupational Therapist openings in different parts of New Zealand. But whilst healthcare is a major focus of Align Recruitment, we also like to hear from people in areas such as Project Management, .NET Development (http://www.alignrecruitment.com/jobs/-/.NET-Development.php), Embedded Software Development, Java Development, Testing Protocol Stacks and seeking related Software Engineering jobs (http://www.alignrecruitment.com/professions.php). There is good opportunity for the right people with the right skills in New Zealand.

New Zealand is a nation with a strong migrant tradition. There are many communities represented here with immigrants coming from the USA, the United Kingdom, Canada, Scandinavia and the Asian continent. A key attraction to New Zealand is the great lifestyle. With a land mass similar to the Untied Kingdom, California or Japan and a population hovering around 4 million - open space is abundant. People with a love of the great outdoors will be in their element with so many activities on offer - from hiking, heliskiing and trekking to cycling, kayaking and fishing all staples of the New Zealand lifestyle (http://www.alignrecruitment.com/lifestyle.html). And, for families - with positive government assistance schemes and a safe environment - this is a great country in which to raise children. New Zealand is a great place for the long-term, but also offers a great way to experience something different in a stable climate during the current turmoil.

The advantage of using Align Recruitment to apply for work in New Zealand is simple - service. Applying for a new position can be a big challenge at the best of times, add to this the prospect of moving countries and there is a considerable amount of the unknown. Align Recruitment assists job seekers with New Zealand immigration and have the contacts within the appropriate organizations to make the transfer as smooth as possible. They also help facilitate with the various New Zealand professional registration boards on behalf of their clients to move their applications along. When they help you find the job you want, Align Recruitment doesn't stop there - their welcome services (http://www.alignrecruitment.com/welcome.html) are designed to assist offshore or expatriate workers shift country and start enjoying the great quality of life New Zealand offers. Align Recruitment will provide information on the cost of living in New Zealand, the lifestyle, the 'Kiwi' way of doing things and also provide detailed tips on how best to prepare for an interview.

Align Recruitment was founded in 2002 by Larry Beck, an American expatriate who holds dual NZ and US citizenships. Prior to immigrating to New Zealand Larry had been working in recruitment in the USA. He says "When I came here I recognised that overseas job candidates looking to work in New Zealand needed more information, about the country, about the types of work, how best to interview for a position in New Zealand, insights into some of the Kiwi ways of doing things and they needed help with immigration. So, I set about launching Align International Recruitment Ltd to provide that information so that overseas job seekers could weigh up the advantages and disadvantages of immigrating to New Zealand and make the right choice for them."

Further Larry added, "We work closely with our applicants - even if there is not an immediate job opening we are always looking to hear from skilled professionals - we are constantly getting requests from employers to find that 'special person'."

For further information - check out the new website www.alignrecruitment.com.

# # #

Contact Information Larry Beck

Align International Recruitment Limited

http://www.alignrecruitment.com/

0064 3 366 8779

Eshoo and Upton Introduce Bill to Provide Relief for Millions with Arthritis

2009-02-27T01:47:00.000+02:00

Eshoo and Upton Introduce Bill to Provide Relief for Millions with Arthritis

A new bill introduced in the U.S. House of Representatives today will strengthen efforts to prevent, control and cure arthritis - the nation's most common cause of disability. The bi-partisan legislation introduced by U.S. Reps. Anna Eshoo (D-Calif.) and Fred Upton (R-Mich.), will address a disease that impacts more than 46 million adults and nearly 300,000 children.

Atlanta, GA (PRWEB) February 26, 2009 -- A new bill introduced in the U.S. House of Representatives today will strengthen efforts to prevent, control and cure arthritis - the nation's most common cause of disability. The bi-partisan legislation introduced by U.S. Reps. Anna Eshoo (D-Calif.) and Fred Upton (R-Mich.), will address a disease that impacts more than 46 million adults and nearly 300,000 children.

"As the leading cause of disability in the United States, we must do more to help treat, cure, and ultimately prevent this disease that affects one in five American adults. This legislation will encourage doctors to pursue pediatric rheumatology to help the thousands of children who suffer from juvenile arthritis and have no access to the right care," says Rep. Eshoo.

The American College of Rheumatology and the Arthritis Foundation applaud the efforts of Eshoo and Upton for introducing the Arthritis Prevention, Control and Cure Act and urge Congress to take swift action.

"Arthritis and rheumatic diseases will likely touch every American in some stage of their lives - either as patients or caregivers. This is a serious issue and should be treated as seriously as we treat other diseases. We must require our lawmakers to take action and send a message to the 46 million that they have not been forgotten in health care," explains Sherine Gabriel, MD, president of the American College of Rheumatology.

According to the Arthritis Foundation, the personal and financial burden of arthritis on our society is enormous and action must be taken now. Currently, arthritis disables 19 million Americans and takes a $128 billion toll annually on the U.S. economy in direct and indirect medical costs.

"Even as the number of people with arthritis rises, federal funding for arthritis research has declined in today's dollar, and intervention programs that could limit the impact are being underutilized," says John H. Klippel, MD, president and CEO of the Arthritis Foundation.

The Arthritis Prevention, Control and Cure Act would enhance rheumatic disease research and expand efforts to prevent, treat and care for people with arthritis and related rheumatic diseases by:

• Enhancing the Centers for Disease Control and Prevention's public health activities related to arthritis

• Expanding and strengthening National Institutes of Health programs relating to juvenile arthritis

• Establishing a juvenile arthritis population database

• Enhancing support for training programs

• Establishing a loan repayment program for pediatric rheumatologists to address the country's severe shortage of these critical health care providers

"This important legislation takes the offensive in our effort to provide relief to the 46 million children and adults who suffer from arthritis each day," says Representative Upton. "We cannot be complacent - few realize arthritis is the most common cause of disability in the United States, inflicting severe, debilitating pain for one out of every five adults. We are long overdue in finding a cure for arthritis, and this measure will boost efforts needed to conquer this disease."

The American College of Rheumatology and the Arthritis Foundation urge Americans, both young and old, to show support for this bill by contacting their members of Congress. Call the AMA Grassroots Hotline at (800) 833-6354 or visit www.arthritis.org/advocacy.php

About the American College of Rheumatology

The American College of Rheumatology is an organization of and for physicians, health professionals, and scientists that advances rheumatology through programs of education, research, advocacy and practice support that foster excellence in the care of people with arthritis and rheumatic and musculoskeletal diseases. It represents more than 8,000 members worldwide who maintain a strong commitment to research and education, advancing the understanding of rheumatic diseases, and discovering new therapies to treat these diseases.

About the Arthritis Foundation

The Arthritis Foundation is the leading health organization addressing the needs of some 46 million Americans living with arthritis, the nation's most common cause of disability. Founded in 1948, with headquarters in Atlanta, the Arthritis Foundation has multiple services points located throughout the country.

The Arthritis Foundation is the largest private, not-for-profit contributor to arthritis research in the world, funding more than $400 million in research grants since 1948. The foundation helps individuals take control of arthritis by providing public health education; pursuing public policy and legislation; and conducting evidence-based programs to improve the quality of life for those living with arthritis.

###

Contact Information Carol Galbreath

Arthritis Foundation

http://www.arthritis.org/advocacy.php

404-965-7595

Preparing for the Next Disaster: Dialysis Community Briefs Hill About Emergency Response

2009-02-26T23:45:00.000+02:00

Preparing for the Next Disaster: Dialysis Community Briefs Hill About Emergency Response

"Dialysis patients represent one of the most at risk segments of the population during a natural disaster," said Bill Numbers, Vice President of Operations Support and Incident Commander for Disaster Planning and Response at Fresenius Medical Care North America (FMCNA).

Washington, D.C. (PRWEB) February 26, 2009 -- "Dialysis patients represent one of the most at risk segments of the population during a natural disaster," said Bill Numbers, Vice President of Operations Support and Incident Commander for Disaster Planning and Response at Fresenius Medical Care North America (FMCNA). Numbers was in Washington to speak with an audience of congressional staffers focused on safeguarding the lives of dialysis patients in a natural disaster. The event, said Numbers, should remind everyone that "we always need to be ready and we must constantly work to be better prepared."

The briefing organized by the Kidney Community Emergency Response Coalition (www.KCERcoalition.com) and Fresenius Medical Care (www.ultracare-dialysis.com) looked at the problem of Chronic Kidney Disease (CKD) as well as ongoing emergency response and recovery efforts. With CKD rates skyrocketing, Chief Medical Officer and Senior Executive VP for FMCNA, Dr. Michael Lazarus explained that educating the public, policy-makers, and emergency response teams is more important than ever. Looking at data for the period between 1997 and 2006, Lazarus pointed to across-the-board increases in CKD rates:

• 106% for Hispanic Americans.

• 98% for Asian Americans.

• 55% for Native Americans.

• 49% for African Americans.

• 42% for Caucasians.

Since Kidney patients typically need four hours of dialysis three days each week in order to eliminate waste, toxins and extra fluids from their system, these increases also underscore the need for emergency planning. Any interruption caused by storms, floods, fires, earthquakes and other natural disasters that might affect electrical power, water lines or make routine travel impractical is life-threatening.

Thinking ahead is even more important than ever. "We're lucky that the dialysis community and emergency responders are working together to prevent the loss of lives," said Bill Numbers. "We simply need to ensure that we are doing everything we can, including educating the public."

Since March is National Kidney Month, briefing organizers hope to focus attention on the impact of natural disasters on dialysis patients. They also want the public to know what is already being done. Kelly Mayo, Project Director, Kidney Community Emergency Response Coalition, spoke about her organization's work with dialysis providers around the country. And Numbers described the evolution of FMCNA's response and recovery efforts, beginning with the Northeast power outage in 2003 through Hurricane Ike and Gustav. In 2008, Numbers said over 100 clinics and 8000 patients were affected during the 3 hurricanes in August through September 2008. During that time, Fresenius provided care to more than 500 non-Fresenius patients and brought in 4 large generators and diesel fuel to supplement local alternative power in Houston and Beaumont communities.

Reflecting on the importance of response and recovery efforts by Fresenius, KCER, and others, Bill Numbers said:

"We are committed to doing this whenever we have to and at whatever the cost. When it comes to dialysis patients, they have no options in a disaster. It is a huge responsibility to safeguard the lives of these individuals and families. And we will continue to work with government and other health providers to prevent the loss of life."

Kidney Community Emergency Response Coalition (KCER) mission is to collaboratively develop, disseminate, implement and maintain a coordinated preparedness and response framework for the kidney community in the event of any type of emergency or disaster. The KCER Coalition membership is open to anyone. To join the Coalition, visit our website and download a contact card or e-mail kcer(at)network7(dot)esrd(dot)net. Emergency preparedness resources and information on the KCER's current activities can be found on their website, www.KCERcoalition.com.

Fresenius Medical Care (FMCNA) is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.6 million individuals worldwide. Through its network of 2,297 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 177,059 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P). More information can be found at: www.ultracare-dialysis.com.

Contact:

David Shapinsky

202-302-4904

dshapinsky(at)obassociates(dot)net

# # #

Contact Information David Shapinsky

http://www.ultracare-dialysis.com

202-302-4904

Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign

2009-02-26T11:45:00.000+02:00

Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign

Radiotherapy Clinics of Georgia and News/Talk 750 WSB are teaming up to extend the Prostate Proactivity Campaign. The metro-Atlanta campaign has been extended to include a screening event Saturday, February 28, from 9 a.m. to 5 p.m. at Kroger located at 540 Lakeland Plaza in Cumming, GA.

Atlanta, GA (PRWEB) February 26, 2009 -- Metro Atlanta men will have an additional opportunity to receive a free and potentially life-saving prostate cancer screening through The Prostate Proactivity Campaign, an educational outreach effort of Radiotherapy Clinics of Georgia and News/Talk 750 WSB. The campaign has been extended to include a screening event Saturday, February 28, from 9 a.m. to 5 p.m. at Kroger located at 540 Lakeland Plaza in Cumming.

During the Prostate Proactivity screening, representatives from RCOG will be on hand to provide information about prostate health, prostate cancer treatment (http://www.prostrcision.com/) options and prostate cancer individual cure rates (http://www.prostrcision.com/qa/cure-rate.php). The Take Control of Your Prostate pamphlet will also be available.

According to the American Cancer Society, prostate cancer is the second leading cause of cancer death in American men, and one in six men will be diagnosed with the disease during his lifetime. However, with early detection and proper treatment the cure rate is nearly 100 percent.

"Prostate cancer can be cured if properly treated. And the earlier the diagnosis, the better the long-term chance of cure. This is why it is worth being knowledgeable about and tested regularly for this disease. Keep in mind that prostate cancer is typically slow growing, so men who are diagnosed have the time to learn about the treatment methods that lead to cure," said Dr. Frank Critz, medical director and director of prostate cancer research at RCOG.

Prostate cancer is detected through a simple blood test known as a PSA test (http://www.prostrcision.com/qa/about-prostate-cancer.php), which determines the level of prostate-specific antigen in the body. Men 50 years of age and older should be screened annually for prostate cancer. African American men and men with a family history of prostate cancer need to begin testing at 40 years of age because they are at a higher risk of developing prostate cancer.

"News/Talk 750 WSB has always been committed to providing strong community support," said Dan Kearney, vice president and general manager of News/Talk 750 WSB. "We are happy to bring another free prostate cancer screening to the Atlanta community to improve survival rates through early detection and awareness of treatment options."

The Third Annual Prostate Proactivity (http://wsbradio.com/prostate/) Campaign kicked off January 2009 on Martin Luther King Jr. Day with a prostate cancer screening at South Dekalb Mall in Decatur. Six additional screenings were held throughout the metro Atlanta area prior to the additional screening scheduled for Saturday, February 28.

If you have prostate cancer questions (http://www.prostrcision.com/qa/), or to learn more about prostate cancer surgery (http://www.rcog.com/) and Radiotherapy Clinics of Georgia, visit RCOG.com and ProstRcision.com or call 1-800-952-7687.

About Radiotherapy Clinics of Georgia:

Radiotherapy Clinics of Georgia is a Center of Excellence for prostate cancer treatment and research. Each year hundreds of men travel to receive prostate cancer treatment in Atlanta, Georgia (http://www.rcog.com/about/our-facilities.php) from RCOG. RCOG is one of the oldest prostate seed implant programs in the world. The first prostate implant for prostate cancer at RCOG was performed in 1977, and the first patient was treated with the combination therapy now called ProstRcision in 1979. Dr. Frank Critz, founder and medical director of RCOG, developed the ProstRcision procedure and has treated more than 8,000 patients with the disease in the past 25 years. RCOG is the only source for ProstRcision, in which two forms of radiation therapy are used to destroy the prostate gland. To date, nearly 12,000 men have received treatment with ProstRcision at RCOG's seven Metro Atlanta clinics. To learn more, please visit rcog.com.

###

Contact Information Caitlin Mangum

Radiotherapy Clinics of Georgia

http://www.rcog.com/

404-835-4521

Keith Hanks

ProstRcision.com

http://www.prostrcision.com/

404-541-9780

Pharmacists Encourage Patients To Seek Their Guidance When Choosing OTC Medications

2009-02-25T19:45:00.000+02:00

Pharmacists Encourage Patients To Seek Their Guidance When Choosing OTC Medications

Eighty-three percent of Patients Select OTC Products Recommended by Their Pharmacist

Washington, D.C. (Vocus) February 25, 2009 -- According to the most recent Pharmacy Today Over-the-Counter Product Survey conducted by the American Pharmacists Association (http://www.pharmacist.com/) (APhA), pharmacists believe that 83 percent of consumers purchase over-the-counter products that were recommended by their pharmacist. With more than 100,000 nonprescription medications on the market and more than 1,000 active ingredients, it's critical that patients consult their pharmacist to maximize the benefits from medications and minimize the potential for harmful drug interaction and/or side effects.

The survey, completed by nearly 1,000 APhA member and non-member pharmacists, also reveals that on average pharmacists counsel 31 patients per week about over the counter medications. Patients who seek their pharmacist's advice include patients suffering from an acute or chronic condition (92 percent), patients that are worried about using an OTC product with other prescription medications (84 percent), and patients worried about taking OTC products with a specific disease/condition (74 percent).

"Pharmacists are the only health professionals specifically trained in nonprescription medications," said John A. Gans, APhA's Chief Executive Officer. "Patients can take an active role in self care by reading medication labels, knowing the active ingredients in their medications, and asking their pharmacist questions."

One of APhA's goal in conducting the annual Pharmacy Today Over-the-Counter Product Survey is to educate consumers that pharmacists have the knowledge and training to help them select right OTC medications. As part of the survey, pharmacists are asked to tabulate the OTC products they recommend per week in 77 different product categories. The results of the survey are published as a supplement to the February issue of Pharmacy Today (http://www.pharmacytoday.org/index.htm). Click here to view the entire Pharmacy Today Over-the-Counter (http://www.pharmacytoday.org/index.htm) Supplement.

As the medication experts, pharmacists are trained in both prescription and over-the-counter medications and can provide patients with important information about how medications may interact with certain foods, other medicines or dietary supplements. Pharmacists are the most accessible health care providers and APhA encourages patients to actively seek their advice about the proper use of medications.

About the American Pharmacists Association (APhA)

The American Pharmacists Association (http://www.pharmacist.com/), founded in 1852 as the American Pharmaceutical Association, represents more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States. APhA members provide care in all practice settings, including community pharmacies, health systems, long-term care facilities, managed care organizations, hospice settings, and the uniformed services.

###

Contact Information Erin Wendel

American Pharmacists Association

http://www.pharmacist.com/

202.429.7558

Clinical Guidelines for Treating Chronic Pain Highlight Opioid Addiction Risk Assessment

2009-02-25T12:45:00.000+02:00

Clinical Guidelines for Treating Chronic Pain Highlight Opioid Addiction Risk Assessment

Expert panel finds that SOAPP® is likely to be helpful for risk assessment and stratification

Newton, MA (PRWEB) February 25, 2009 -- Inflexxion, Inc., a company that creates scientifically validated and cost-effective solutions for critical areas of health care, is pleased to announce that its Screener and Opioid Assessment for Patients with Pain (SOAPP) has been identified by an expert panel as likely to be helpful for assessing the risk of opioid addiction in patients with chronic non-cancer pain.

SOAPP is a brief paper-and-pencil self report tool that allows clinicians to assess a patient's risk of addiction before initiating opioid therapy.

The multi-disciplinary panel of experts, convened by the American Pain Society and the American Academy of Pain Medicine, conducted a comprehensive review of the evidence to develop a set of authoritative clinical guidelines on the use of opioid medications to treat chronic non-cancer pain. The guidelines, published in the February 2009 issue of The Journal of Pain (Volume 10, Number 2), recommend that clinicians routinely conduct a complete benefit-to-harm evaluation before starting opioid therapy, and do periodic follow-up screenings of patients who may be at risk for abuse or addiction.

"Proper patient selection is critical and requires a comprehensive benefit-to-harm evaluation that weighs the potential positive effects of opioids on pain and function against potential risks," write the authors. "Thorough risk assessment and stratification is appropriate in every case."

According to the authors, screening tools that assess the potential risks associated with continuous opioid therapy (COT) based on patient characteristics are likely to be helpful for risk stratification. The authors identify SOAPP Version 1 and the revised version, SOAPP-R, as among the tools that appear to have "good content, face, and construct validity."

In addition to SOAPP, the guidelines highlight the utility of Inflexxion's Current Opioid Misuse Measure (COMM)®, a complementary tool for identifying whether a patient, throughout the course of long-term opioid therapy, may be exhibiting aberrant behaviors associated with abuse of opioid medications.

"We at Inflexxion are very pleased to see both SOAPP and COMM included in these recommendations," says Kevin L. Zacharoff, M.D., Director of Medical Affairs at Inflexxion. "These guidelines underscore the importance of risk assessment and reassessment in this patient population. The inclusion of the SOAPP and COMM in these recommendations helps to validate Inflexxion's mission, which is to help to reduce health-related risks, enhance clinical outcomes, and positively influence quality of care."

The SOAPP and COMM tools are available for download at no cost through Inflexxion's PainEDU website (www.PainEDU.org), along with a clinician tutorial that includes video case examples.

SOAPP was developed by Inflexxion with support from the National Institutes of Health (NIH) and an unrestricted educational grant from Endo Pharmaceuticals.

About Inflexxion, Inc.

Founded in 1989, Inflexxion creates innovative behavioral health solutions for prevention, education, and disease management. Our clinically tested programs address substance abuse and addiction, chronic pain management, college health, and other health and wellness issues. Our pharmaceutical risk management division provides Risk Evaluation and Mitigation Strategy (REMS) assistance to companies that research, manufacture, and market opioid pain medications and other therapeutic agents with potential abuse problems. Key offerings include NAVIPPRO(TM), PainEDU.org, painACTION.com, and SOAPP®. Inflexxion is based in Newton, MA.

###

Contact Information Lara Romanowski

Inflexxion

http://www.painedu.org

617-614-0406

Texas Oncology Encourages Texans To Kick Colorectal Cancer with Screenings

2009-02-25T09:45:00.000+02:00

Texas Oncology Encourages Texans To Kick Colorectal Cancer with Screenings

Texas Oncology is inviting Texans to kick colorectal cancer by encouraging friends and loved ones to go for a routine colorectal cancer screening. Colorectal cancer is the second-leading cancer killer of men and women combined in the United States, and the disease is estimated to have claimed 9,570 Texans in 2008.

Paris, Texas (PRWEB) February 24, 2000- - Texas Oncology is inviting Texans to kick colorectal cancer (http://www.texasoncology.com/media-center/fact-sheets/colorectal-cancer/kick-colorectal-cancer.aspx) by encouraging friends and loved ones to go for a routine colorectal cancer screening. Colorectal cancer (http://www.texasoncology.com/media-center/fact-sheets/colorectal-cancer.aspx) is the second-leading cancer killer of men and women combined in the United States, and the disease is estimated to have claimed 9,570 Texans in 2008.

Colon and rectal cancers occur with equal frequency in both sexes. It is vital that both men and women age 50 and over and those with increased risk factors be screened regularly (http://www.texasoncology.com/media-center/fact-sheets/colorectal-cancer.aspx) for this deadly disease. Despite the high likelihood of detection with screening, it is projected that 40 percent of the over-50 population in the United States, more than 39 million people by 2010, will not be screened for colorectal cancer. If all people over age 50 were screened routinely, research shows at least half of colorectal cancer deaths could be prevented.

Colorectal cancer often lacks symptoms in its early stages, and because almost all colorectal cancer cases are diagnosed in patients ages 50 and up, regular screening helps lead to early detection, which increases the five-year survival rate from the disease to 90 percent.

"Regular colorectal cancer screenings save lives. Your doctor can recommend the best screening for you, but a colonoscopy is the most common," said Dr. Michael Kerley (http://www.texasoncology.com/providerresults.aspx?id=1410&terms=%40Locations_Location_8+274), medical and radiation oncologist at Texas Oncology-Paris. "Everyone over age 50 should make routine colorectal cancer screenings a priority to kick colorectal cancer before it strikes or catch it early when it's most treatable."

Risk Factors

Besides age and race, other risk factors for colorectal cancer include:

•Family History: People with a family history of colorectal cancer have a greater risk of being diagnosed with the disease.

•Diet: A lower chance of being diagnosed with colorectal cancer is a good reason to stay in shape. Overweight and obese people have a higher risk of developing the disease.

•Lynch Syndrome: This inherited condition affecting the body's genes increases the likelihood of a colorectal cancer diagnosis. In many cases, the positive diagnosis occurs before age 45. Texas Oncology has genetic testing available at some locations to determine if patients have the gene mutation associated with Lynch Syndrome.

•Other Health Problems: Diabetics and people who have a history of polyps and inflammatory bowel disease also have an increased risk for a positive diagnosis.

Screening Types

Screening tests for rectal and colon cancer are not as difficult as many people perceive them to be. In fact, most patients tolerate the screenings very well. Physicians can recommend several different screening tests for colorectal cancer. Among them, a Fecal Occult Blood Test (FOBT) or Fecal Immunochemical Test checks for blood in the stool. Another option is a sigmoidoscopy. During this procedure, a physician uses a tube with a light connected to a tiny video camera to analyze the rectum and lower part of the colon.

The most common screening test is a colonoscopy, where the rectum and entire colon are examined through a scope to detect growths or polyps that could potentially pose a threat (see sidebar graphic for a description of a colonoscopy).

March is colorectal cancer awareness month. For more information on kicking colorectal cancer, visit TexasOncology.com (http://www.texasoncology.com).

About Texas Oncology

Texas Oncology delivers high-quality cancer care with leading-edge technology and advanced treatment and therapy options available to help patients achieve "More breakthroughs. More victories." in their fights against cancer, right in their own communities. Texas Oncology, a pioneer in community-based cancer care, is an independent oncology practice with sites of service throughout Texas and southeastern New Mexico.

Texas Oncology patients have the opportunity to take part in some of the most promising clinical trials in the nation for a broad range of cancers. In fact, Texas Oncology has played an integral role in gaining Food and Drug Administration (FDA) approval for 24 of the latest 30 cancer therapies.

Texas Onocology is affiliated with US Oncology, the nation's foremost cancer treatment and research network accelerating the availability and use of evidence-based medicine and shared best practices. With more than 1,250 physicians at 480 locations in 39 states, the US Oncology network provides Texas Oncology with access to the latest advancements in therapies, clinical research, and technology, as well as best-in-class clinical and operational processes that help to advance the quality, safety, and cost effectiveness of cancer care.

For more information, visit http://www.texasoncology.com or call 1-888-864-I CAN (4226).

###

Contact Information Alison Zvolanek

214-665-1319

Bumrungrad International Hospital Won 1st Place as "Best Website for International Medical Travel"

2009-02-24T16:45:00.000+02:00

Bumrungrad International Hospital Won 1st Place as "Best Website for International Medical Travel"

Bumrungrad International hospital - www.bumrungrad.com, won 1st Place as "Best Website for International Medical Travel" at the 2008 Consumer Health World Awards event in the US capitol. Bumrungrad.com is a hospital website serving international audiences, Thais, and expatriates. The Award organizers said the site "makes it easy for prospective patients to find the information they are interested in, provide an efficient way to make inquiries and request appointments, and provide information to help international medical travelers understand how to get care at Bumrungrad."

Bangkok, Thailand (PRWEB) February 24, 2009 -- Bumrungrad International (http://www.bumrungrad.com) won 1st Place as "Best Website for International Medical Travel" at the 2008 Consumer Health World Awards event in the US capitol.

Bumrungrad.com is a hospital website serving international audiences, Thais, and expatriates. The Award organizers said the site "makes it easy for prospective patients to find the information they are interested in, provide an efficient way to make inquiries and request appointments, and provide information to help international medical travelers understand how to get care at Bumrungrad."

JWT Connect, Bangkok, helped the hospital redesign its home page, focusing on audience segmentation and content architecture, earlier this year.

The award adds to a list of honors (http://www.bumrungrad.com/hospital-news.aspx) achieved by Bumrungrad in 2008, including "Thailand's Most Innovative Company" by Chulalongkorn University's School of Business; top medical tourism destination (Tourism Authority of Thailand); top Thai company for quality of products and services (Asian Wall Street Journal); and excellence in information technology (Assoc. of Medical Directors of Information Systems).

About Bumrungrad International

Bumrungrad International (http://www.bumrungrad.com), is Southeast Asia's premier private hospital and a regional referral center for advanced care, offering 554 beds, 30 specialty centers, 940 medical specialists and over 800 nurses. It is Asia's first JCI accredited hospital and serves more than one million patients yearly from 190 different countries.

###

Contact Information Mr. Kaorop Wongprasert

Bumrungrad International Hospital

http://www.bumrungrad.com

+66-2-667-2212

Bederra Corporation Launches New Billing Services Division Expected to Add up to $500,000 in Revenue

2009-02-24T13:45:00.000+02:00

Bederra Corporation Launches New Billing Services Division Expected to Add up to $500,000 in Revenue

Bederra Corporation (Pink Sheets: BEDA), a medical imaging and diagnostic Company launches new Physician Billing Services Division to provide small and medium sized doctor groups out sourced billing services as part of its commitment to synergistically diversify the company's business.

Houston, TX (PRWEB) February 24, 2009 -- Bederra Corporation (http://www.bederra.com) (Pink Sheets: BEDA), a medical imaging and diagnostic Company launches new Physician Billing Services Division to provide small and medium sized doctor groups out sourced billing services as part of its commitment to synergistically diversify the company's business.

Bederra Corporation (http://www.bederra.com), through its Lumar Imaging, Inc. subsidiary, has experienced staff that has been providing these services on a limited basis to select physicians. The new division is not only expected to generate new cash flow for the company, but will also increase the number of future physician referrals leading to additional revenue.

In today's market, many physicians have difficulty in navigating the constantly changing rules of Insurance providers, Medicare and Medicaid billing. Qualified individuals necessary to perform these services are in high demand and in short supply. Bederra has cultivated these types of professionals for years with careful training and will now offer those services to private practices.

Four percent of all insurance claims for services are rejected by insurance companies. Ninety-five percent of those rejected claims are due to input errors or incomplete information on the claim form. Millions of dollars per year go uncollected by physician's practices due to these errors. By correcting previous errors, and pursuing new monies generated, Bedderra can grow the working relation of the MRI practice and the private practice physician.

"Due to this demand for greater services, the company plans to offer this service to more physicians with the net effect of obtaining greater market penetration for its diagnostic imaging services and creating an additional profit center that will increase the overall company's sales and profits," stated Graham Williams, CEO of Bederra.

About Bederra Corp. (http://www.bederra.com):

Bederra Corporation (http://www.bederra.com), through its wholly owned subsidiaries Diagnos, Inc. and Lumar Imaging, Inc., provides multiple modality diagnostic medical imaging services to the greater Houston area and the world famous Texas Medical Center. The Company's business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact:

Bederra Corp.

info (at) bederra (dot) com

Investor Relations

Mark Jones

281-920-0955

###

Contact Information Mark Jones

Bederra Corporations

http://www.Bederra.com

281-920-0955

Horses Are Discovering Healthy And Tasty Benefits Of Himalayan Salt Licks Now Available From HorseSalt.Com Dealers

2009-02-24T09:45:00.000+02:00

Horses Are Discovering Healthy And Tasty Benefits Of Himalayan Salt Licks Now Available From HorseSalt.Com Dealers

Every year, veterinarians recommend giving horses salt as an essential nutritional supplement (http://HorseSalt.com). But Himalayan salts are richer in minerals, providing extra health benefits for horses.

Grand Rapids, MN (PRWEB) February 24, 2009 -- Horse owners are being licked with love as they discover Himalayan salts now available from HorseSalt.com.

Horses gravitate towards salts that are healthier and tastier. Salts imported from the Himalayan Mountains in Pakistan are amongst the healthiest salts for horses (http://HorseSalt.com). Himalayan salts contain over 84 chelated, healthy, bioavailable minerals.

"When I was researching the best salts for horses I found that ones with the most minerals and healthiest crystal structures come from the Himalayan Mountains. White pressed salt blocks are devoid of essential minerals. Salt, when it is pressed and baked, destroys the healthy crystalline structures," says Patricia Reszetylo, who has been a horse lover and equine specialist for over 30 years.

There are many health benefits for horses when they consume Horse Salts from the Himalayas:

1) Reduced stress from heat and cold and other environmental factors equals better performance from your horse. Australian farmers have noted better weight gain, under normal weather circumstances, and less weight loss during heat Other benefits include:

2) Reduced water bloating

3) Retains a healthy cellular pH balance, allowing better performance.

4) Faster, less stressful metabolism of food

5) Better respiratory and sinus health, bone strength, better sleep and vascular health

HorseSalt.com is the leading provider of Himalayan salt licks for horses.

To find your nearest HorseSalt.com dealer, or to become a dealer, visit the website at http://HorseSalt.com, or call HorseSalt.com at 218-327-4042

Patricia Reszetylo, President of HorseSalt.com, is available for media interviews.

Contact:

Patricia Reszetylo

218-327-4042

###

Contact Information Patricia Reszetylo

HorseSalt.com

http://HorseSalt.com

7083274042

Ugandan Children Receive Life-Saving Treatment For Heart Defects At Children's National Medical Center

2009-02-23T21:45:00.000+02:00

Ugandan Children Receive Life-Saving Treatment For Heart Defects At Children's National Medical Center

Through partnership with Samaritan's Purse and Gift of Life, patients travel to United States **Media Note: Patients will be at Children's National for farewell visit on Tuesday, February 24**

Washington, DC --On February 12, two Ugandan children received life-saving procedures at Children's National Medical Center (http://www.childrensnational.org/?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda) to correct severe heart defects. Without cardiac surgery, the young boys would likely have died before adulthood, but they now have a normal life expectancy.

As part of the Phase I of a global initiative to bring attention to the health needs of Ugandan children, 15-month-old Daniel Kamaramasu and 2 ½-year-old Allan Wassanyi traveled 5,000 miles to receive treatment unavailable at home. Daniel, who was born with a blocked valve between his heart and lungs, was successfully treated using a cardiac catheterization balloon procedure by Michael Slack, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocId=470&Name=Michael%20Slack?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda). Allan, who had a very large hole in his heart, underwent successful open heart surgery by Richard Jonas, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocID=1195&Name=Richard%20Jonas?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda).

The boys came to Children's National through a partnership with international relief organization Samaritan's Purse, Gift of Life International (GOLI), and other organizations. Through this partnership, pediatric cardiologist Craig Sable, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocId=424&Name=Craig%20Sable?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda) has led seven medical missions to Uganda in an effort to provide treatment for patients and ultimately build a sustainable cardiac surgery program in Uganda. More than 100 children have received life-saving treatment since the program began in 2003.

"With the dedication of organizations like Samaritan's Purse and Gift of Life, patients from around the world have access to the expert pediatric care that is available to children in the United States," said Dr. Sable.

Added Cindy Bonsall, director of Samaritan's Purse's Children's Heart Project: "We're glad this partnership has enabled so many Ugandan children to receive the cardiac care they deserve. We're glad they will be returning home soon with a second chance at life."

A key component of the missions to Uganda has been training Ugandan surgeons. Through training provided by Dr. Sable and colleagues, Ugandan surgeons are now on the verge of doing simple cardiac procedures on their own. Dr. Sable directs the Telemedicine Program at Children's National, which provides training and educational opportunities around the world.

The groups have joined forces to implement "Our Hearts Are In Uganda," which will focus all of GOLI's efforts in Uganda. The first phase of the program included treatment for Daniel, Allan, and three other children at hospitals in the United States. The next phase will bring 25 more Ugandan children to hospitals throughout the world to receive life-saving treatment for heart defects.

"We have saved the lives of more than 10,000 children, and through this partnership, we hope to expand our reach, to ultimately create a program in Uganda to ensure that all the children have access to the medical care they need," said Lou del Rosario, vice chairman of GOL District 7230, who was instrumental in raising funds for Allan's operation.

MEDIA NOTE: The patients will be returning to Children's National for a farewell visit on Tuesday, February 24. The patients and Dr. Craig Sable will be available for interviews. Contact Emily Dammeyer or Jenn Leischer at 202-476-4500.

About Children's National Medical Center (http://www.childrensnational.org/about/?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda)

Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children's has been serving the nation's children for more than 135 years. Children's National is proudly ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. For more information, visit www.childrensnational.org.

About Samaritan's Purse

Samaritan's Purse identifies children needing life-saving heart treatment through its' Children's Heart Project. The international relief organization identifies children overseas who need heart surgery, matches them with hospitals and specialists willing to donate their time and services, places them with a local host family, and arranges international travel and an interpreter. More than 550 children from nine countries have been brought to North America for medical and surgical care not available in their home countries.

About Gift of Life International

Gift of Life is a Rotary based program in more than 50 Rotary Clubs and Districts on 6 continents. GOLI aims to save as many children's lives as possible by providing life saving open heart surgery to children from infancy to 18 years of age with congenital heart defects. GOLI has been responsible for saving more than 10,000 lives during the past 33 years.

###

Contact Information Emily Dammeyer

Children's National Medical Center

http://www.childrensnational.org

202-476-4500

Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance

2009-02-23T13:45:00.000+02:00

Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance

Carestream Molecular Imaging today released convenient, cost-effective kits for performing western blots -- a popular analytical technique used to detect proteins.

New Haven, CT (Vocus) February 23, 2009 -- Carestream Molecular Imaging, a division of Carestream Health, Inc., today released convenient, cost-effective kits for performing western blots (http://mistore.carestreamhealth.com) -- a popular analytical technique used to detect proteins. KODAK X-SIGHT Western Kits provide industry-leading components and step-by-step protocols designed to deliver peak performance from X-SIGHT Nanosphere Conjugates in western blots.

"The X-SIGHT Nanosphere Conjugates, when used with the components supplied in the Western Kit, outperformed our current western blot method," said Kevin McCarthy, Ph.D., Professor, Department of Pathology, LSU Health Sciences Center-Shreveport. "The whole process was faster, easier and the signal obtained was immediate, more stable and brighter -- with less background noise."

KODAK X-SIGHT Western Kits are built on X-SIGHT Nanospheres (http://mistore.carestreamhealth.com), which are available in four distinct wavelengths including three in the near-IR range. The kits are offered in several different wavelength combinations that include up to three X-SIGHT Nanosphere Conjugates, making them ideal for multiplex applications (http://mistore.carestreamhealth.com). Each kit is optimized for 10 blots and includes best-in-class membranes and buffers to achieve high signal-to-noise ratios. A separate Accessory Kit is also available for use with any of the X-SIGHT Nanosphere Conjugates or any other commercially available fluorescently-labeled secondary antibody conjugate (nanoparticle or dye).

The new kit delivers added productivity and can reduce costs when compared with purchasing each component separately or in larger quantities than may be necessary. Components suppliers include Fisher BioReagents (Fairlawn, NJ) part of Thermo Fisher Scientific and Millipore Corporation (Billerica, Mass.).

The kits are available worldwide. U.S. customers can place orders directly or through channel partners. For more information, go to http://mistore.carestreamhealth.com.

About Carestream Molecular Imaging

Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/development market segments. For more information, visit mi.carestreamhealth.com or call 1-877-747-4357, express code 7. Outside of the United States, call 1-203-786-5657.

About Carestream Health, Inc.

Carestream Health, Inc., is a leading provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for the life science research and drug discovery/development market segments; and x-ray film and digital x-ray products for the non-destructive testing market. Headquartered in Rochester, N.Y., and serving customers in more than 150 countries, Carestream Health is an independent company operating within the family of companies owned by Onex Corporation (TSX: OCX.TO) of Toronto, Canada. For more information about Carestream Health, contact your Carestream Health representative or visit www.carestreamhealth.com.

KODAK is a trademark of Kodak used under license.

X-SIGHT is a trademark of Carestream Health.

###

Contact Information Jim Barillo

Carestream Health, Inc.

http://mistore.carestreamhealth.com

585-627-6440

Robette Brooks

CCS PR

303-699-8861

Separating Fact from Bioidentical Hype

2009-02-21T10:45:00.000+02:00

Separating Fact from Bioidentical Hype

Hot from Menopausal Symptoms and Bothered by the Media Hype about Hormone Replacement? People are hearing about bioidentical hormone replacement along with more traditional types of prescribed hormone medication from the Oprah show and other media. Lets separate Fact from Fiction. The word "bioidentical" is not an accurate medical description of this new, unregulated substance and it certainly is not exactly like the hormones the body produces otherwise there would not be a measurable and clinically evident toxic build-up in the body. In "Revitalize Your Hormones: Dr. Dale's 7 Steps to a Happier, Healthier, and Sexier You" (Wiley; May 2005), Dr. Theresa Dale offers a medically proven natural alternative to invasive and dangerous hormone replacement therapies. Dale invented the world's only clinically proven, FDA registered, homeopathic hormone rejuvenation formulas used for restoring hormone balance without side effects.

(PRWEB) February 19, 2009 -- Hot from Menopausal Symptoms and Bothered by the Media Hype about Hormone Replacement? People are hearing about bioidentical hormone replacement along with more traditional types of prescribed hormone medication from the Oprah show and other media. Lets separate Fact from Fiction. The new buzz word "bioidentical" is deceptive. It's not an accurate medical description of this new, unregulated substance and it is not exactly like the body produces. Clearly there is a measurable and clinically evident toxic build-up in the body.

Bioidentical hormone replacement is not natural even though it originates from yam or soy; it has been compounded and thus a synthetic. That's right; health providers perform thousands of before and after saliva tests on patients and it is clear that there is a toxic build up of all hormone replacement including bioidentical HRT.

Women are wary of recent warnings linking hormone replacement therapy with an increased risk for heart disease, stroke and breast cancer, more and more women are turning to alternative and natural ways to balance their hormone levels. Studies have shown that using hormones such as Prempro, Othro-Prefest or Premphase and bioidentical HRT causes the body to shut down production of its own hormones creating a dependency. Hormone replacement therapy can also elevate existing hormone levels to toxically high amounts, which can tax the adrenal glands, burden the liver, kidneys, and circulatory and immune systems.

Yet, there is a superior way to get both clinically proven and evidence based relief without being exposed to the toxic effects of ALL of these drugs. Health providers throughout the US are using FDA registered NuFem & EndoPure Homeopathic Hormone Rejuvenation, developed by Theresa Dale, ND, CCN, NP.

In "Revitalize Your Hormones: Dr. Dale's 7 Steps to a Happier, Healthier, and Sexier You" (Wiley; May 2005; $15.95/Paper), Dr. Theresa Dale offers a medically proven alternative to invasive and dangerous hormone replacement therapies. With over 20 years of experience as a Naturopathic Doctor, Certified Clinical Nutritionist and researcher, Dr. Dale has helped women balance their hormone levels through safe, non-toxic program. The world's only clinically proven homeopathic hormone rejuvenation formulas used for restoring hormone balance without side effects. These formulas actually produce healthy hormone levels in women of various ages, and eliminate symptoms such as hot flashes, mood swings, low libido, low energy and irregular menses. The formulas are FDA approved and regulated and are prepared at an FDA registered pharmacy. The remedy goes through a lengthy preparation processes. For example, an herb or substance is diluted and prepared in a manner so that just a micro amount of the original substance is left in the final formula. This method of natural preparation enhances all the properties of the herb and amplifies its efficacy. Homeopathic medicine has been used for 200 years throughout the world, and is natural without toxic side effects. See The Wellness Center website for more education about Homeopathy.

The medical establishment's approach to balancing hormones fails to embrace the concept of the body as a natural living system that is capable of self-repair. Its regimens are based on the premise that people need to look outside our bodies for hormone help via one-size-fits-all drugs. The only hormones that are safe for the human body are the ones the body makes. By using a totally natural and homeopathic program, it is possible to restore emotional, physical and sexual health by following simple and safe individualized nutritional and exercise guidelines.

For more information, call Theresa Dale's office at 866 962 6484.

Theresa Dale, ND, CCN, NP

Founder, The Wellness Center For Research & Education, Inc.

Dean, California College of Natural Medicine

www.wellnesscenter.net

###

Contact Information Theresa Dale

The Wellness Center

http://www.wellnesscenter.net

866 962 6484

Dr. Theresa Dale, ND, CCN, NP

The Wellness Center

http://www.wellnesscenter.net

805 984 7200

Baltimore LASIK Eye Surgeon Walter J. Stark, M.D. of the Wilmer Eye Institute at Johns Hopkins Joins Trusted LASIK Surgeons Directory

2009-02-20T11:45:00.000+02:00

Baltimore LASIK Eye Surgeon Walter J. Stark, M.D. of the Wilmer Eye Institute at Johns Hopkins Joins Trusted LASIK Surgeons Directory

Trusted LASIK Surgeons announced today that LASIK and refractive eye surgery expert Doctor Walter Stark of the Wilmer Laser Vision Center at Johns Hopkins in Baltimore, Maryland has joined the Trusted LASIK Surgeons Directory, an informational resource for consumers looking for vision correction and improvement through laser and lasik eye surgery or another refractive eye surgery procedure. Dr. Stark's practice primarily serves patients seeking laser eye surgery throughout Maryland including Arlington, Bethesda, and Frederick, Washington D.C., Dover and Newark in Delaware, as well as surrounding states, and patients visiting from international locations.

Baltimore, MD (PRWEB) February 20, 2009 -- Trusted LASIK Surgeons (http://www.trustedlasiksurgeons.com/index.htm) announced today that Walter J. Stark, M.D. (http://trustedlasiksurgeons.com/baltimore_lasik_surgeon_walter_stark_md.htm), of the Wilmer Laser Vision Center at Johns Hopkins in Baltimore, Maryland (http://www.hopkinsmedicine.org/wilmer/lasik) is listed in the Trusted LASIK Surgeons Directory (http://www.TrustedLASIKSurgeons.com), an informational resource for consumers looking to improve their vision through laser eye surgery or another refractive eye surgery procedure. Dr. Stark's practice primarily serves patients seeking improve uncorrected visual acuity through LASIK and laser eye surgery in Baltimore, Arlington, Columbia, Rockville and Washington, D.C. areas (http://www.trustedlasiksurgeons.com/baltimore_lasik_surgeons.htm). Dr. Stark also treats patients seeking LASIK and other vision correction procedures throughout Maryland (http://trustedlasiksurgeons.com/maryland_lasik_surgeons.htm), as well as surrounding states and international countries.

Trusted LASIK Surgeons directory endeavors to list only those LASIK eye surgeons who are among the best in the United States. To accomplish this, Trusted LASIK Surgeons screens each eye surgeon based on experience, premier patient care, and professional credentials. Trusted LASIK Surgeons estimates that Dr. Stark's outstanding professional credentials place him among the top 1% of LASIK and refractive surgeons in the United States.

The most significant professional qualifications that set Dr. Stark apart from the majority of LASIK eye surgeons in the United States are based on his extensive research, teaching and consulting expertise. Dr. Stark serves as a Distinguished Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of The Wilmer Eye Institute Wilmer Eye Institute (http://www.hopkinsmedicine.org/wilmer) at the Johns Hopkins Medical Institutions, which is repeatedly ranked as the top eye care center in the nation in surveys by U.S. News & World Report and Ophthalmology Times. He has served as a principal investigator for 1 FDA study for vision correction lasers, has written 10 textbook chapters and textbooks, and has published over 400 scientific articles for major peer-reviewed eye journals. In addition, he serves in an editorial capacity for Ophthalmology Times and Ophthalmology World News. Dr. Stark has made over 400 presentations at major eye meetings throughout the world. He was the former chairman and is currently a consultant for the US Food and Drug Administration's (FDA) Ophthalmologic Devices Panel. He is also a consultant for the National Eye Institute, as well as many organizations dedicated to improving vision, including the Medical Eye Bank of Maryland, Tissue Eye Banks International, Project ORBIS, and the National Foundation for Eye Research among others. His considerable contributions to the field of refractive eye surgery have earned him the respect of his peers throughout the world.

In the course of helping patients improve their vision, Dr. Stark has performed thousands of LASIK eye surgery and laser vision correction procedures. With over 18 years of experience in laser vision surgery, including LASIK, as well as in other refractive surgery procedures such lens implants, Dr. Stark has the proven know-how to provide patients with the best care available.

Certified by the American Board of Ophthalmology, this highly qualified LASIK eye surgeon is an active member of many professional organizations. The American Academy of Ophthalmology, where he has served for several years as the Chairman of the Committee for Research and Regulatory Agencies and the Chairman for the Committee for Ophthalmic Technology Development, has honored him with an Achievement Award, a Life Achievement Honor Award, the Binkhorst Medal Lectureship and a Senior Honor Award. In addition, Dr. Stark is a member of the American Medical Association, the Cornea Society (formerly the Castroviejo Society), the International Society for Contact Lens Research, the Microbiology and Immunology Group, Ophthalmic Genetics Study Club, the Association for Research in Vision and Ophthalmology (ARVO), the Eye Study Club. Locally, he is a member of the Maryland Ophthalmological Society.

Dr. Stark's practice at The Wilmer Eye Institute at Johns Hopkins provides state-of-the-art patient care, including use of the IntraLase system for "All-Laser" or "Bladeless" LASIK, Wavefront Based ("Custom") LASIK and PRK, and the iLASIK procedure, which includes WaveScan Technology, IntraLase, and Visx Advanced CustomVue treatments. Dr. Stark treats a full range of vision problems including nearsightedness (myopia), farsightedness (hyperopia), astigmatism (blurred vision), and presbyopia. Dr. Stark offers not just LASIK and PRK (laser eye surgery procedures), but other procedures like RLE/CLE (lens implants), phakic implants, limbal relaxing incisions, and cataract lens implants procedures to ensure patients have a complete range of options when it comes to choosing the right procedure to improve their vision. Other eye doctors and eye surgeons commonly seek Dr. Stark to perform their LASIK or other refractive surgery procedure. In addition, new patients who have suffered problems from a LASIK eye surgery or another vision correction procedure performed by another surgeon regularly seek Dr. Stark to manage and treat their problems.

Dr. Stark's most treasured honor was the dedication of the Walter J. Stark, M.D. and Margaret C. Mosher Center for Cataract and Corneal Diseases. Margaret Mosher, his long-time patient and friend, made the Center possible through her generous donation. In addition, he has been recognized as one of Baltimore's "Top Doctors" by Baltimore magazine and one of Washington D.C. "Top Doctors" by Washingtonian magazine.

"Dr. Stark was among the first group of refractive eye surgeons in the world to perform Excimer laser surgery when he was the principle investigator for the VISX FDA Phototherapeutic study in the early 1990's," said James J. Salz, M.D., Chief Executive Officer of Trusted LASIK Surgeons. "He has made major contributions to the field of Excimer laser surgery and cataract surgery techniques through hundreds publications and lectures throughout the world. We are honored to have him as a member of the Trusted Lasik Surgeons Directory."

"Providing safe and effective refractive surgery is our goal. We are more conservative than many refractive surgeons and, therefore, will not offer you the surgery if you are not a good candidate," said Walter Stark, M.D. Distinguished Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of The Wilmer Eye Institute at The Johns Hopkins Medical Institutions.

Visit Baltimore, Maryland LASIK Surgeon Walter J. Stark, M.D. profile page at Trusted LASIK Surgeons (http://www.trustedlasiksurgeons.com/baltimore_lasik_surgeon_walter_stark_md.htm)

To learn more about Dr. Stark's refractive surgery practice, please visit Baltimore, MD, LASIK eye surgeon Walter J. Stark, M.D. at Wilmer Eye Institute (http://www.hopkinsmedicine.org/wilmer/employees/cvs/Stark.html)

For more on why consumers should consider surgeons listed in the Trusted LASIK Surgeons directory for their vision correction needs, please visit: Why choose a Surgeons from the Trusted LASIK Surgeon's Directory (http://www.trustedlasiksurgeons.com/why_use_a_trusted_lasik_surgeon.htm)

The screening process and standards used by Trusted LASIK Surgeons are located at How Are LASIK Surgeons Qualified at Trusted LASIK Surgeons? (http://www.trustedlasiksurgeons.com/how_are_lasik_surgeons_qualified_at_tls.htm)

To find a highly accomplished LASIK and refractive specialist in your local area who has been qualified and listed in the Trusted LASIK Surgeons directory, please visit Trusted LASIK Surgeons Directory (http://www.trustedlasiksurgeons.com/find_a_lasik_eye_surgeon.htm)

SOURCE: Trusted LASIK Surgeons

About Trusted LASIK Surgeons, Inc.

Trusted LASIK Surgeons, Inc. (Trusted LASIK Surgeons) is a premier LASIK, laser eye surgery, and refractive eye surgery directory service whose primary mission is to assist consumers in finding the best and most qualified LASIK and vision correction surgeons in their local area in the United States. To accomplish this, Trusted LASIK Surgeons uses a unique screening process where each prospective LASIK eye surgeon must meet the minimum required qualifications set by Trusted LASIK Surgeons. These qualifications for these doctors are based on experience (not just in LASIK but complete refractive care), research (including FDA approval studies for manufacturers and academic appointments at major universities), publications and lectures (to their peers, not to the public via infomercials) and patient care standards (treating other eye professionals and managing complications from patients first operated on by someone else). All refractive eye surgeons listed at Trusted LASIK Surgeons have qualified, been accepted, and have subscribed to our services. For more information on why we believe consumers interested in LASIK should consider an eye surgeon listed in the Trusted LASIK Surgeon's directory, please visit our website at www.TrustedLASIKSurgeons.com.

Trusted LASIK Surgeons, Inc.

(800) 483-8028

The Wilmer Laser Vision Center

The Wilmer Eye Institute has been performing laser vision correction since the early 1990's and has performed thousands of surgeries to date. Our facilities are state-of-the-art with the most technically advanced equipment designed to make your procedure as safe and efficient as possible. The Wilmer Laser Vision Center utilizes the iLASIK system which includes the VISX WaveScan Wavefront(tm) System, IntraLase FS(tm) Femtosecond Laser, and the VISX STAR S4 IR(tm) Excimer Laser for our laser vision correction procedures. Our laser vision correction surgeons are members of the Trusted LASIK Surgeons Directory. The Wilmer Eye Institute is repeatedly ranked as the top eye care center in the nation in surveys by U.S. News & World Report and Ophthalmology Times. The Wilmer Eye Institute has been a leader in laser vision care and has developed some of the earliest lasers for vision care and pioneered laser removal of corneal scars and laser treatment for corneal diseases. The Wilmer Eye Institute participated in the first clinical trials of laser correction for nearsightedness, farsightedness and wavefront technology and continues to participate in clinical trials for approvals of new advanced excimer laser software and technology. Wilmer is helping to develop the next generation of laser vision correction procedures. The laser surgeons at The Wilmer Laser Vision Center are full-time faculty members of The Johns Hopkins Hospital, Wilmer Eye Institute and are highly trained cornea experts who can help you to understand laser vision correction and its impact on your long-term vision health. The Wilmer Eye Institute trains more eye experts, are entrusted to perform more eye research than any other center and have contributed to amazing advances in eye care. For more information about the Wilmer Laser Vision Center, please visit: www.hopkinsmedicine.org/wilmer/lasik.

The Wilmer Laser Vision Center at Green Spring Station

10753 Falls Road, Pavilion II, Suite 455

Lutherville, MD 21093

phone: 410-583-2802

fax: 410-583-2842

The Wilmer Ophthalmological Institute

The Johns Hopkins University School of Medicine

600 N. Wolfe Street

Baltimore, MD, 21287

phone: (410) 955-5490

fax: (410) 614-9172

About Wilmer Eye Institute

The Wilmer Eye Institute has long been recognized for bringing together ophthalmologists consistently ranked by their peers as among the finest internationally, with a specially trained and highly experienced team of nurses cited by patients for their knowledge, responsiveness, and sensitivity. Working together, they have established and refined a flexible approach for delivering state-of-the-art ophthalmic care - and created the Wilmer Eye Care Pavilion as the optimal setting for that approach. We welcome you to visit us. For more information about the Wilmer Eye Institute, please visit: www.hopkinsmedicine.org/wilmer.

# # #

Contact Information James J. Salz, M.D.

Trusted LASIK Surgeons, Inc.

http://www.TrustedLASIKSurgeons.com

+1 (800) 483-8028

Online Marketing Dept.

LanceThink Media

http://www.LanceThinkMedia.com

+1 (800) 846-6208

The Wand Employed in Offices of Dr. Jan Linhart

2009-02-19T10:45:00.000+02:00

The Wand Employed in Offices of Dr. Jan Linhart

Dentist emphasizes patient comfort and pain-free dental care

New York, NY (PRWEB) February 19, 2009 -- Dr. Jan Linhart, an acclaimed Manhattan cosmetic and restorative dentist (http://www.drlinhart.com), uses state-of-the-art equipment to ensure the best possible care for his patients. One of the most advanced pieces of equipment now employed in his offices is The Wand.

"The most painful part of dental work is often the injection of anesthetics," states Dr. Linhart. "That's why we use The Wand--it's virtually painless." The Wand is an anesthetic delivery system of the highest caliber. It includes a computerized injector that minimizes the opportunity for painful human error. Dr. Linhart explains, "If anesthetics are administered too quickly, it hurts. The Wand controls pressure and flow rate to ensure a comfortable injection." The dentist controls the machine with a foot pedal and applies the anesthetic with a tiny needle nestled in a pen-like applicator.

"It looks nothing like a syringe," continues Dr. Linhart. "The non-threatening appearance works to reassure patients. Additionally, it is lightweight and easy to handle, which makes application easier and safer."

One key feature of The Wand is that anesthesia is induced before the needle is inserted, and the flow of anesthetic precedes the needle throughout the entire process. Dr. Linhart states, "Because of this unique system, the patient can hardly feel the needle. That was one of the major factors in our deciding to use the equipment. Whether someone is getting a crown, a root canal or an implant, our use of The Wand makes the process as comfortable as possible. Patient comfort is very important to us."

The Wand is not the only pain-reducing product currently used in the offices of Dr. Linhart. "We also use the Waterlase MD." Made by Biolase Technologies, Inc., this high-tech drill uses a laser and water to effectively vaporize cavities and unwanted tissue. "The Waterlase MD can be used in place of a traditional drill and often removes the need for anesthesia entirely. This laser has many of the same strengths as The Wand: it is easy to control, precise, and it reduces pain and anxiety," says Dr. Linhart.

He concludes, "At our offices, a patient never has to fear the ominous sights and sounds of old-fashioned syringes and drills--it's a much more positive experience for all involved."

Dr. Jan Linhart, DDS, a Manhattan based cosmetic and restorative dentist attracts patients from around the world. Come by our Park Avenue Manhattan office to inquire about our Pearinbrite teeth whitening procedures and other state-of-the-art dental services that we offer including implant dentistry (http://www.drlinhart.com/implants.html), porcelain veneers (http://www.drlinhart.com/veneer.html), and more.

###

Contact Information Ellen S. Linhart

http://www.drlinhart.com

212-682-5180

HealthSmart Contracts with MEDai for Predictive Modeling Technology to Improve Members’ Health and Reduce Costs

2009-02-19T09:45:00.000+02:00

HealthSmart Contracts with MEDai for Predictive Modeling Technology to Improve Members’ Health and Reduce Costs

HealthSmart will use MEDai’s award-winning predictive modeling technology to identify members who may currently be at the lower end of a disease stage, but are likely to incur high costs in the near future, one to two years out. The program couples the identification process with an effective disease management program to focus on monitoring and proactively treating the identified members.

(Vocus) February 19, 2009 -- HealthSmart Care Management Solutions, LP, formerly Q-elements, Ltd., and MEDai, Inc. announced a strategic partnership that provides industry leading predictive modeling technology to HealthSmart’s clients and their members. HealthSmart will use MEDai’s award-winning predictive modeling technology to identify members who may currently be at the lower end of the five disease stages, but are likely to incur high costs in the near future, one to two years out. The program couples the identification process with an effective disease management program to focus on monitoring and proactively treating the identified members.

"Each member is assessed for health risks and appropriate inclusion in an acute or chronic health management program," said Pamela Coffey, Chief Operating Officer of HealthSmart Care Management Solutions, LP. Rather than solely focusing on existing treatment, HealthSmart draws upon MEDai’s forecasting abilities to identify individuals with evolving healthcare needs. Ms. Coffey added, “We assess the member's clinical condition and knowledge of their disease and implement an individualized care plan and educational program. The HealthSmart Predictive Management Clinical Team discusses the member's medication regimen and any life style changes that may be required to improve their quality of life.”

"MEDai's predictive modeling solution goes beyond affecting the bottom line," said Steve Epstein, CEO and President of MEDai, Inc. "it allows care management organizations to proactively educate and manage their population. In this case, HealthSmart's Predictive Management Clinical Team acts as the patient’s advocate, ensuring that every member has a chance at living a healthy and active life," he added.

About MEDai

MEDai, Inc., headquartered in Orlando, FL, is a leading health information company offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting edge technology, payors and care management organizations are able to forecast patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time, and improve outcomes.

About HealthSmart Holdings, Inc. (Parent Company of HealthSmart Care Management Solutions, LP)

HealthSmart Holdings, Inc., along with its healthcare-related subsidiaries, comprise an innovative healthcare solutions company servicing over 1.7 million members and managing over $3.2 billion in claims. The company is headquartered in Dallas, Texas, and currently maintains 11 service operations around the country. The HealthSmart companies are dedicated to delivering integrated self-funded solutions by utilizing proprietary products and services, including provider networks, care management, prescription benefit management, primary clinic management, benefit administration and stop-loss. The HealthSmart mission is to improve member health, reduce costs and deliver “smarter” healthcare solutions. To learn more about HealthSmart Holdings, Inc. and its related companies, please visit their web site (http://www.healthsmart.com).

###

Contact Information Ralph Gill

HealthSmart

http://www.healthsmart.com

214.574.2461

Landmark Trial Provides Vital Information for Cardiac Disease Treatment

2009-02-19T01:45:00.000+02:00

Landmark Trial Provides Vital Information for Cardiac Disease Treatment

NorthShore University HealthSystem Ted Feldman, M.D., Lead Investigator

Evanston, IL. -- NorthShore University HealthSystem (http://www.northshore.org/) (NorthShore) has played a leading role in a landmark clinical trial comparing two forms of treatment for patients with severe coronary artery disease (CAD). The results were published on-line in this week's issue of the New England Journal of Medicine.

The SYNTAX trial was a clinical research study that compared percutaneous coronary intervention (PCI) with drug-eluting stents and coronary artery bypass surgery (CABG) in patients with three-vessel and left main coronary disease. The trial results did not show any statistically significant differences between PCI and CABG in rates of death or heart attack, an excess of stroke in the CABG treated patients, and a greater need for repeat PCI procedures in the stent treated patients. These are better outcomes for PCI than have been seen in prior trials in less complex patients.

"At NorthShore, we experienced stunning outcomes in patients whose only option would have previously been bypass surgery," said Ted Feldman, M.D, F.S.C.A.I., Director of Cardiac Catheterization Laboratory, NorthShore University HealthSystem, and a lead investigator of the trial. "The data in this study will provide cardiologists with additional information as they determine treatment therapy for patients with complex CAD."

The trial is the first randomized, controlled clinical trial to compare these two treatments in patients with left main disease and/or three-vessel disease, who are typically treated with CABG and represent a population with far more complex anatomy and advanced disease than those studied in prior drug-eluting stent (DES) clinical trials.

There were 1,800 patients enrolled in the randomized arm of the trial. All patients were assessed by a multidisciplinary team including an interventional cardiologist and a cardiac surgeon. If both the cardiologist and surgeon felt that they could offer equivalent complete revascularization, patients were randomized 1:1 into one of the two treatment strategies. If either the cardiologist or surgeon felt that one or the other revascularization technique was the preferred option, due to technical considerations or co-morbidity, for example, then patients were recruited into one of two parallel, nested registries for PCI or CABG. Thus, patients in the PCI registry had been rejected for cardiac surgery.

About NorthShore University HealthSystem

Headquartered in Evanston, Ill., NorthShore University HealthSystem (NorthShore) is a comprehensive, fully integrated, healthcare delivery system that serves the greater North Shore and northern Illinois communities. The system includes three Hospitals--Evanston Hospital, Glenbrook Hospital and Highland Park Hospital--and a fourth, Skokie-based Rush North Shore Hospital, to be added in January 2009. In addition, the healthsystem has more than 2,000 affiliated physicians, including a 550-physician, multispecialty physician group practice with over 70 office locations-- NorthShore University HealthSystem Medical Group. Further, NorthShore is committed to excellence in its academic mission and supports teaching and research as the principal teaching affiliate of the University of Chicago's Pritzker School of Medicine. The NorthShore University HealthSystem Research Institute, with more than $100 million of grants, focuses on clinical and translational research, including leadership in outcomes research and clinical trials.

NorthShore has annual revenues of $1.5 billion and a staff of more than 8,000. The healthsystem has significant capabilities in a wide spectrum of clinical programs, including cancer, heart, orthopaedics, high-risk maternity and pediatrics. NorthShore is a national leader in the implementation of innovative technologies, including electronic medical records, (EMR ). In 2003, the healthsystem was among the first in the country to successfully launch a systemwide EMR with demonstrable benefits in quality, safety, efficiency and service to patients. NorthShore has been recognized by multiple national organizations for this notable achievement. Visit http://www.northshore.org/

CONTACT: Amy Ferguson

Senior Director, Public Relations

NorthShore University HealthSystem

(847) 570-3146

###

Contact Information Amy Ferguson

Northshore University HealthSystem

http://www.northshore.org/

847-570-3146